8i Acquisition 2 and EUDA Health Limited, a Singapore-based digital health platform, announced an extension of the SPAC’s due diligence review of the deal from May 31 to June 15.
Announced in April, the deal carries an enterprise value of $583 million. Cash proceeds raised will consist of 8i’s approximately $86.3 million in trust (less any redemptions). Additional earnouts in the form of 9 million total shares will be awarded post-transaction close if EUDA’s share price reaches $15, $20 and $25 at set periods over three years. Read more.
